Generic Pharmasec Ltd deals in pharmaceutical activities /services and trades in equity sharesBusiness Overview: GPL started as a manufacturer and trader of organic and inorganic chemicals, dyes and pigments and then shifted its business activities to buying, selling and distribution of pharmaceutical, medicinal and medicated preparations and also decided to...
Genpharmasec Limited has announced the publication of its financial results for the quarter ended June 30, 2025. On a consolidated basis, the company reported total income from operations of ₹12.74 Cr and a net profit after tax of ₹1.22 Cr for the quarter. Basic Earnings Per Share stood at ₹0.02....
Genpharmasec Limited has confirmed that there is no deviation or variation in the use of proceeds from its Rights Issue. The company raised Rs 48.45 Cr through the Rights Issue, which was allotted in February 2024. The funds are being utilized precisely as outlined in the Letter of Offer, allocated...
Genpharmasec Limited has completed the acquisition of a 70% stake in Derren Healthcare Private Limited for INR 34.15 Cr. This strategic move makes Derren Healthcare a subsidiary, significantly expanding Genpharmasec's presence in pharmaceutical formulations manufacturing. Derren Healthcare is a research-focused company specializing in generics and finished formulations, also operating as...
Genpharmasec Limited has announced a certificate from its Registrar and Share Transfer Agent confirming that no physical share certificates were received for dematerialization during the quarter. This means all shares remain in their current form with no new securities converted to electronic form in this period. This update reflects the...
Genpharmasec Limited has announced the Annual Secretarial Compliance Report for the year ended March 31, 2025, confirming full adherence to all applicable corporate governance and SEBI regulations without any deviations or penalties. The report highlights that the company maintains up-to-date policies, conducts performance evaluations of its board and committees, and...
